Mint Tower Capital Management B.V. »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Mint Tower Capital Management B.V.

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Mint Tower Capital Management B.V. from 13F filings

Historical chart of Mint Tower Capital Management B.V. investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Mint Tower Capital Management B.V. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Mint Tower Capital Management B.V.

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.0M 8.5M 0.94

More positions owned by Mint Tower Capital Management B.V.

Royal Caribbean Group Note 6.000% 8/1 (Principal)
On Semiconductor Corp Note5/0 (Principal)
On Semiconductor Corp Note 0.500% 3/0 (Principal)
Splunk Note 1.125% 6/1 (Principal)
Lantheus Hldgs Note 2.625%12/1 (Principal)
Microstrategy Note2/1 (Principal)
Morgan Stanley Put Option (MS)
Ionis Pharmaceuticals Note4/0 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Exxon Mobil Corporation Put Option (XOM)
Sarepta Therapeutics Note 1.250% 9/1 (Principal)
Apple (AAPL)
Li Auto Note 0.250% 5/0 (Principal)
Hess (HES)
Churchill Capital Corp Vii Com Cl A (CVII)

View all positions for Mint Tower Capital Management B.V.

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Lazard Asset Management
Calamos Advisors
Invesco
Advent Capital Management
Opti Capital Management
Steelhead Partners
Aequim Alternative Investments
Citadel Advisors
Davidson Kempner Capital Management
Readystate Asset Management
D. E. Shaw & Co
Zazove Associates
Wellington Management Company
State Street Corporation

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1